View Document Preview and Link
Open Document File Size: 1,32 MB Share Result on Facebook
City HCV / Cambridge / / Company Cystic Fibrosis Foundation Therapeutics Incorporated / Janssen Pharmaceutica N.V. / Wall Street Journal / Contents VERTEX PHARMACEUTICALS INCORPORATED / Mitsubishi Tanabe Pharma Corporation / VERTEX PHARMACEUTICALS INC / EDGAR Online Inc. / The NASDAQ Global Select Market Securities / / Continent North America / Europe / / Country Germany / France / Japan / United States / Canada / Australia / United Kingdom / Ireland / / Currency USD / / Event FDA Phase / Product Issues / Business Partnership / Funding / / IndustryTerm corporate Web site / research / manufacturing / / MedicalCondition liver failure / pulmonary exacerbations / rheumatoid arthritis / TELAVIC (telaprevir) HCV Infection / cirrhosis / hepatitis C / pulmonary / multiple sclerosis / KALYDECO (ivacaftor) Indication HCV Infection / cystic fibrosis / Influenza / Autoimmune Diseases / serious diseases / cancer / genetic disease / disease / INCIVO (telaprevir) HCV Infection / chronic / Huntington's disease / chronic lung infections / HCV / infection / DRUG CANDIDATES Drug Candidate Mechanism Cystic Fibrosis / inflammation / fibrosis / / Organization World Health Organization / UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON / D.C. / Centers for Disease Control and Prevention / European Medicines Agency / U.S. Food and Drug Administration / European Commission / I.R.S. / European Union / Ministry of Health / / Person Mechanism Cystic / Mechanism Cystic Fibrosis / / / Position Director Independence Principal Accountant / principle driver / Candidate / / Product ribavirin / VX-661 / VX-509 / CFTR genes / CFTR protein / R117H / VX-135 / VX-809 / G551D / JAK3 / United States / CFTR proteins / F508del / / ProvinceOrState Massachusetts / / PublishedMedium The Wall Street Journal / / RadioStation CFTR / / Technology Biotechnology / pharmacokinetics / genotype / drug development / / URL http / SocialTag